...
首页> 外文期刊>Postgraduate Medical Journal >Imaging in pulmonary hypertension, part 1: Clinical perspectives, classification, imaging techniques and imaging algorithm
【24h】

Imaging in pulmonary hypertension, part 1: Clinical perspectives, classification, imaging techniques and imaging algorithm

机译:肺动脉高压中的影像学,第1部分:临床观点,分类,影像学技术和影像学算法

获取原文
获取原文并翻译 | 示例
           

摘要

Pulmonary arterial hypertension (PAH) is an uncommon condition associated with significant morbidity and mortality. It has diverse aetiology with differing clinical presentations, imaging features and treatments that range from surgical treatment of proximal chronic thromboembolic disease to targeted medical therapies in small vessel disease. Current classification of pulmonary hypertension (PH) is clinically based and groups diseases with similar pathophysiological mechanisms and therapeutic approaches. Groupings include conditions characterised by diffuse small vessel diseases such as idiopathic PAH, PH secondary to chronic hypoxic lung disease, left sided cardiac disease, chronic large vessel obstruction such as chronic thromboembolic disease and a miscellaneous group of diseases. The physiological manifestation of all of these diseases is increased pulmonary vascular resistance and PAH and while clinical features may provide a clue to diagnosis imaging plays a fundamental role in establishing a precise diagnosis and therefore guides therapy. A broad range of imaging modalities is available for the patient with suspected PH including chest radiograph, echocardiography, ventilation/perfusion scintigraphy, catheter pulmonary angiography as well as cross-sectional CT and MRI. Each modality has its strengths and limitations and different techniques may be used at different stages of diagnostic investigation and frequently complement each other. For example, while MRI and echocardiography permit cardiac structural and functional assessment, CT pulmonary angiography provides exquisite morphological information about the proximal pulmonary vasculature and lung parenchyma but little functional information. Modern cross-sectional imaging techniques (CT and MRI) hold the promise of a comprehensive evaluation of the heart, circulation and lung parenchyma in PH. The authors present a multimodality-imaging algorithm for the investigation of patients with suspected PH though it is acknowledged that there is some variation in practice depending on availability of resources and expertise.
机译:肺动脉高压(PAH)是一种罕见的疾病,与高发病率和高死亡率相关。它具有不同的病因,具有不同的临床表现,影像学特征和治疗方法,从近端慢性血栓栓塞性疾病的外科手术治疗到小血管疾病的靶向药物治疗。当前对肺动脉高压(PH)的分类是基于临床的,并且将具有相似病理生理机制和治疗方法的疾病归为一组。分组包括以弥散性小血管疾病(如特发性PAH),继发于慢性低氧性肺疾病的PH,左侧心脏疾病,慢性大血管阻塞(如慢性血栓栓塞性疾病)和其他疾病为特征的疾病。所有这些疾病的生理表现是肺血管阻力和PAH升高,而临床特征可能为诊断提供线索,影像学在建立精确诊断中起着基本作用,因此指导治疗。疑似PH的患者可使用多种成像方式,包括胸部X光片,超声心动图,通气/灌注闪烁显像,导管肺血管造影以及断层CT和MRI。每种方式都有其优势和局限性,并且在诊断研究的不同阶段可以使用不同的技术,并且常常会相互补充。例如,尽管MRI和超声心动图可以进行心脏结构和功能评估,但CT肺血管造影可以提供有关近端肺血管和肺实质的精妙形态信息,但功能信息很少。现代横断面成像技术(CT和MRI)有望对PH的心脏,循环和肺实质进行全面评估。作者提出了一种多模态成像算法,用于调查疑似PH的患者,尽管该方法在实践中会有所不同,具体取决于资源和专业知识的可用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号